Craft
Pfizer

Pfizer

Phase II Trials Products

25

FY, 2021

Revenue

$81.3 B

FY, 2021

Market Capitalization

$255 B

2022-09-19

Pfizer Summary

Company summary

Overview
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. It operates in two business segments: Pfizer Biopharmaceuticals Group (Biopharma) and Upjohn. The Biopharma segment offers medicines, vaccines, and biosimilars for the treatment of cardiovascular and metabolic diseases, oncology diseases, pneumococcal disease, meningococcal disease and tick-borne encephalitis, chronic immune and inflammatory diseases, as well as rare diseases, including amyloidosis, hemophilia, and endocrine diseases. The Upjohn segment provides products that are used to treat non-communicable diseases across a range of therapeutic areas, including cardiovascular, pain and neurology, psychiatry, urology, and ophthalmology.
Type
Public
Founded
1849
HQ
New York, NY, US | view all locations
Website
https://www.pfizer.com
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Albert Bourla

    Albert Bourla, Chief Executive Officer and Chairman

  • Mikael Dolsten

    Mikael Dolsten, Chief Scientific Officer and President, Worldwide Research, Development and Medical

  • Lidia Fonseca

    Lidia Fonseca, Chief Digital and Technology Officer, Executive Vice President

  • William Pao

    William Pao, Chief Development Officer, Executive Vice President

Operating MetricsView all

Properties

327
9.9%

FY, 2021

Manufacturing Sites

39
9.3%

FY, 2021

Phase I Trials Products

27

FY, 2021

LocationsView all

101 locations detected

  • New York, NY HQ

    United States

    235 E 42nd St

  • Andover, MA

    United States

    1 Burtt Rd

  • Boulder, CO

    United States

    3200 Walnut St

  • Cambridge, MA

    United States

    1 Portland St

  • Chesterfield, MO

    United States

    875 Chesterfield Pkwy W

  • Collegeville, PA

    United States

    500 Arcola Rd

and 95 others

Pfizer Financials

Summary financials

Revenue (Q2, 2022)
$27.7B
Gross profit (Q2, 2022)
$19.1B
Net income (Q2, 2022)
$9.9B
Cash (Q2, 2022)
$1.8B
Enterprise value
$288.8B

Footer menu